Bionet (1784) — Cash Flow Reinvestment Rate
Bionet (1784) has a Cash Flow Reinvestment Rate of 3.28x as of December 2025, reinvesting NT$93.46 Million (capex NT$38.02 Million plus investments NT$55.44 Million) from operating cash flow of NT$28.46 Million. Check 1784 cash to earnings ratio to evaluate the quality of earnings relative to operating cash generation.
Reinvestment Rate
Total Reinvested
Operating Cash Flow
Capital Expenditures
Bionet Cash Flow Reinvestment Rate (2019–2025)
Historical reinvestment intensity for Bionet across 7 annual periods. Explore 1784 cash flow to debt ratio to assess how comfortably operating cash covers total debt obligations.
Annual Cash Flow Reinvestment Rate for Bionet (2019–2025)
Year-by-year capital reinvestment analysis for Bionet. For live market cap and broader valuation context, see Bionet market cap and net worth.
| Year | Reinvestment Rate | Total Reinvested (TWD) | Operating CF | Capex | YoY Change |
|---|---|---|---|---|---|
| 2025 | 2.04x | NT$302.51 Million | NT$148.04 Million | NT$132.18 Million | ▼ -53.3% |
| 2024 | 4.38x | NT$772.28 Million | NT$176.49 Million | NT$103.49 Million | ▲ +53.6% |
| 2023 | 2.85x | NT$436.21 Million | NT$153.09 Million | NT$26.28 Million | ▲ +653.0% |
| 2022 | 0.38x | NT$35.82 Million | NT$94.65 Million | NT$32.91 Million | ▼ -82.4% |
| 2021 | 2.15x | NT$29.80 Million | NT$13.88 Million | NT$16.66 Million | ▲ +101.9% |
| 2020 | 1.06x | NT$78.35 Million | NT$73.66 Million | NT$38.03 Million | ▼ -95.0% |
| 2019 | 21.27x | NT$56.78 Million | NT$2.67 Million | NT$11.60 Million | — |